Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Responsiveness to reduced dosage of rituximab in Chinese patients with neuromyelitis optica.
[Ultrahigh field MRI in context of neurological diseases.]
Paraneoplastic neuromyelitis optica spectrum disorder associated with metastatic carcinoid expressing aquaporin-4.
Self-rating makes the difference: Identifying palliative care needs of patients feeling severely affected by multiple sclerosis.
CD98 is a potential target for ablating B cell clonal expansion and autoantibody in multiple sclerosis.
CX3CR1 in multiple sclerosis.
Radiolabeling and in vitro / in vivo evaluation of N-(1-adamantyl)-8-methoxy-4-oxo-1-phenyl-1,4-dihydroquinoline-3-carboxamide as a PET probe for imaging cannabinoid type 2 receptor.
Meta-analysis of prevalence.
Treatment of pediatric multiple sclerosis.
Quantification of retinal neural loss in patients with neuromyelitis optica and multiple sclerosis with or without optic neuritis using optical coherence tomography.
Multiple sclerosis susceptibility alleles in African Americans.
A questionnaire survey of patients and carers of patients prescribed Sativex as an unlicensed medicine.
Cyclosporine in the treatment of a case of fulminant and refractory acute disseminated encephalomyelitis.
The primary vascular dysregulation syndrome: implications for eye diseases.
Accuracy of a custom physical activity and knee angle measurement sensor system for patients with neuromuscular disorders and gait abnormalities.
A Novel Bmal1 Mutant Mouse Reveals Essential Roles of the C-Terminal Domain on Circadian Rhythms.
Human pluripotent stem cell-derived neural constructs for predicting neural toxicity.
Multiple sclerosis: Brain volume loss strengthens disease measure.
Factors associated with health-related quality of life among older people with multiple sclerosis.
Thalamic atrophy and cognitive impairment in clinically isolated syndrome and multiple sclerosis.
Biomarkers in multiple sclerosis: an update for 2014.
Features of neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies.
Cohort Study Comparing the Berg Balance Scale and the Mini-BESTest in Ambulatory People With Multiple Sclerosis.
Prognostic Factors of MS Conversion in Optic Neuritis.
Correction: Comparative Study on the Therapeutic Potential of Neurally Differentiated Stem Cells in a Mouse Model of Multiple Sclerosis.
Pages
« first
‹ previous
…
358
359
360
361
362
363
364
365
366
…
next ›
last »